TCIM
AGRX

TIAA CREF Investment Management’s Agile Therapeutics AGRX Stock Holding History

TIAA CREF Investment Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20
Closed -$128K – 3198
2017
Q1 		$128K Hold
20
– – ﹤0.01% 3029
2016
Q4 		$228K Sell
20
-1
-5% -$14K ﹤0.01% 3026
2016
Q3 		$287 Buy
21
+1
+5% +$14.3K ﹤0.01% 3005
2016
Q2 		$301K Buy
20
+4
+25% +$54.8K ﹤0.01% 3032
2016
Q1 		$202K Hold
16
– – ﹤0.01% 2974
2015
Q4 		$318K Hold
16
– – ﹤0.01% 3005
2015
Q3 		$220K Sell
16
-6
-27% -$107K ﹤0.01% 3032
2015
Q2 		$383K Buy
+22
New +$469K ﹤0.01% 3025

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return